Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist

Varun K A Sreenivasan, Oleg A. Stremovskiy, Timothy A. Kelf, Marika Heblinski, Ann K. Goodchild, Mark Connor, Sergey M. Deyev, Andrei V. Zvyagin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Somatostatin (SST) is a peptide neurotransmitter/hormone found in several mammalian tissue types. Apart from its natural importance, labeled SST/analogues are utilized in clinical applications such as targeting/diagnosis of neuroendocrine tumors. We report on the development and characterization of a novel, recombinant, fluorescent somatostatin analogue that has potential to elucidate somatostatin-activated cell signaling. SST was genetically fused with a monomeric-red fluorescent protein (mRFP) as the fluorescent label. The attachment of SST to mRFP had no detectable effect on its fluorescent properties. This analogue's potency to activate the endogenous and transfected somatostatin receptors was characterized using assays of membrane potential and Ca 2+ mobilization and immunocytochemistry. SST-mRFP was found to be an effective somatostatin receptor agonist, able to trigger the membrane hyperpolarization, mobilization of the intracellular Ca 2+ and receptor-ligand internalization in cells expressing somatostatin receptors. This complex represents a novel optical reporter due to its red emission spectral band suitable for in vivo imaging and tracking of the somatostatin receptor signaling pathways, affording higher resolution and sensitivity than those of the state-of-the-art radiolabeling bioassays.

Original languageEnglish
Pages (from-to)1768-1775
Number of pages8
JournalBioconjugate Chemistry
Volume22
Issue number9
DOIs
Publication statusPublished - 21 Sep 2011
Externally publishedYes

Fingerprint

Somatostatin Receptors
Somatostatin
Pharmacology
Proteins
Cell signaling
Membranes
Bioassay
Labels
Tumors
Assays
Ligands
Cells
Tissue
Imaging techniques
Somatostatin-Secreting Cells
Neuroendocrine Tumors
Peptide Hormones
Biological Assay
Membrane Potentials
Neurotransmitter Agents

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Sreenivasan, V. K. A., Stremovskiy, O. A., Kelf, T. A., Heblinski, M., Goodchild, A. K., Connor, M., ... Zvyagin, A. V. (2011). Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjugate Chemistry, 22(9), 1768-1775. https://doi.org/10.1021/bc200104u

Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. / Sreenivasan, Varun K A; Stremovskiy, Oleg A.; Kelf, Timothy A.; Heblinski, Marika; Goodchild, Ann K.; Connor, Mark; Deyev, Sergey M.; Zvyagin, Andrei V.

In: Bioconjugate Chemistry, Vol. 22, No. 9, 21.09.2011, p. 1768-1775.

Research output: Contribution to journalArticle

Sreenivasan, VKA, Stremovskiy, OA, Kelf, TA, Heblinski, M, Goodchild, AK, Connor, M, Deyev, SM & Zvyagin, AV 2011, 'Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist', Bioconjugate Chemistry, vol. 22, no. 9, pp. 1768-1775. https://doi.org/10.1021/bc200104u
Sreenivasan VKA, Stremovskiy OA, Kelf TA, Heblinski M, Goodchild AK, Connor M et al. Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. Bioconjugate Chemistry. 2011 Sep 21;22(9):1768-1775. https://doi.org/10.1021/bc200104u
Sreenivasan, Varun K A ; Stremovskiy, Oleg A. ; Kelf, Timothy A. ; Heblinski, Marika ; Goodchild, Ann K. ; Connor, Mark ; Deyev, Sergey M. ; Zvyagin, Andrei V. / Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist. In: Bioconjugate Chemistry. 2011 ; Vol. 22, No. 9. pp. 1768-1775.
@article{ac035a1b5e7b4d299cb892f2359f8f4e,
title = "Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist",
abstract = "Somatostatin (SST) is a peptide neurotransmitter/hormone found in several mammalian tissue types. Apart from its natural importance, labeled SST/analogues are utilized in clinical applications such as targeting/diagnosis of neuroendocrine tumors. We report on the development and characterization of a novel, recombinant, fluorescent somatostatin analogue that has potential to elucidate somatostatin-activated cell signaling. SST was genetically fused with a monomeric-red fluorescent protein (mRFP) as the fluorescent label. The attachment of SST to mRFP had no detectable effect on its fluorescent properties. This analogue's potency to activate the endogenous and transfected somatostatin receptors was characterized using assays of membrane potential and Ca 2+ mobilization and immunocytochemistry. SST-mRFP was found to be an effective somatostatin receptor agonist, able to trigger the membrane hyperpolarization, mobilization of the intracellular Ca 2+ and receptor-ligand internalization in cells expressing somatostatin receptors. This complex represents a novel optical reporter due to its red emission spectral band suitable for in vivo imaging and tracking of the somatostatin receptor signaling pathways, affording higher resolution and sensitivity than those of the state-of-the-art radiolabeling bioassays.",
author = "Sreenivasan, {Varun K A} and Stremovskiy, {Oleg A.} and Kelf, {Timothy A.} and Marika Heblinski and Goodchild, {Ann K.} and Mark Connor and Deyev, {Sergey M.} and Zvyagin, {Andrei V.}",
year = "2011",
month = "9",
day = "21",
doi = "10.1021/bc200104u",
language = "English",
volume = "22",
pages = "1768--1775",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Pharmacological characterization of a recombinant, fluorescent somatostatin receptor agonist

AU - Sreenivasan, Varun K A

AU - Stremovskiy, Oleg A.

AU - Kelf, Timothy A.

AU - Heblinski, Marika

AU - Goodchild, Ann K.

AU - Connor, Mark

AU - Deyev, Sergey M.

AU - Zvyagin, Andrei V.

PY - 2011/9/21

Y1 - 2011/9/21

N2 - Somatostatin (SST) is a peptide neurotransmitter/hormone found in several mammalian tissue types. Apart from its natural importance, labeled SST/analogues are utilized in clinical applications such as targeting/diagnosis of neuroendocrine tumors. We report on the development and characterization of a novel, recombinant, fluorescent somatostatin analogue that has potential to elucidate somatostatin-activated cell signaling. SST was genetically fused with a monomeric-red fluorescent protein (mRFP) as the fluorescent label. The attachment of SST to mRFP had no detectable effect on its fluorescent properties. This analogue's potency to activate the endogenous and transfected somatostatin receptors was characterized using assays of membrane potential and Ca 2+ mobilization and immunocytochemistry. SST-mRFP was found to be an effective somatostatin receptor agonist, able to trigger the membrane hyperpolarization, mobilization of the intracellular Ca 2+ and receptor-ligand internalization in cells expressing somatostatin receptors. This complex represents a novel optical reporter due to its red emission spectral band suitable for in vivo imaging and tracking of the somatostatin receptor signaling pathways, affording higher resolution and sensitivity than those of the state-of-the-art radiolabeling bioassays.

AB - Somatostatin (SST) is a peptide neurotransmitter/hormone found in several mammalian tissue types. Apart from its natural importance, labeled SST/analogues are utilized in clinical applications such as targeting/diagnosis of neuroendocrine tumors. We report on the development and characterization of a novel, recombinant, fluorescent somatostatin analogue that has potential to elucidate somatostatin-activated cell signaling. SST was genetically fused with a monomeric-red fluorescent protein (mRFP) as the fluorescent label. The attachment of SST to mRFP had no detectable effect on its fluorescent properties. This analogue's potency to activate the endogenous and transfected somatostatin receptors was characterized using assays of membrane potential and Ca 2+ mobilization and immunocytochemistry. SST-mRFP was found to be an effective somatostatin receptor agonist, able to trigger the membrane hyperpolarization, mobilization of the intracellular Ca 2+ and receptor-ligand internalization in cells expressing somatostatin receptors. This complex represents a novel optical reporter due to its red emission spectral band suitable for in vivo imaging and tracking of the somatostatin receptor signaling pathways, affording higher resolution and sensitivity than those of the state-of-the-art radiolabeling bioassays.

UR - http://www.scopus.com/inward/record.url?scp=80053067646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053067646&partnerID=8YFLogxK

U2 - 10.1021/bc200104u

DO - 10.1021/bc200104u

M3 - Article

VL - 22

SP - 1768

EP - 1775

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 9

ER -